CZR vs KRYS · rev $5.86B vs P/E 46, rev $235.6M
Caesars Entertainment Corporation (CZR) versus Krystal Biotech Inc (KRYS) — a side-by-side from cached financials, not a winner call.
Caesars Entertainment Corporation (CZR) is a resorts & casinos company listed on US.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Latest reported CZR revenue for 2026-06-30 was $5.86B. Net income was -$160.0M. CZR currently screens at market cap $5.95B.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
CZR currently screens at market cap $5.95B. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Not investment advice. Open the CZR and KRYS stock pages for the full models.
Not investment advice.